Indian Journal of Pharmacy and Pharmacology

Print ISSN: 2393-9079

Online ISSN: 2393-9087

CODEN : IJPPTK

Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...

Article type

Review Article


Article page

57-65


Authors Details

Syamsudin Abdillah*, Yatnita Parama Cita


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 1140

PDF Downloaded: 1456


Potential target plants as anti- sars-cov-2 (Coronavirus): Expectations and challenges


Review Article

Author Details : Syamsudin Abdillah*, Yatnita Parama Cita

Volume : 7, Issue : 2, Year : 2020

Article Page : 57-65

https://doi.org/10.18231/j.ijpp.2020.013



Suggest article by email

Get Permission

Abstract

This review presents the potential target of SARS-CoV-19 therapy and some plants with anti-COVID-19
activity, attained through docking analysis, in vitro and in vivo studies. Furthermore, there are hopes and
challenges in identifying new compounds derived from natural ingredients for therapy.

Keywords: Target of SARS-CoV-19, Natural products, Docking analysis, in vitro.


How to cite : Abdillah S , Cita Y P , Potential target plants as anti- sars-cov-2 (Coronavirus): Expectations and challenges. Indian J Pharm Pharmacol 2020;7(2):57-65

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.